# CVS Health (CVS) SEC filings: latest 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/CVS/filings

> CVS Health (CVS) SEC filings from EDGAR: 10-K filed Feb 10, 2026, 10-Q filed Nov 4, 2026, 8-K filed Nov 4, 2026. 79 filings in the last 12 months.

---

## CVS Health (CVS) SEC filings

CVS Health's latest annual report is a Form 10-K filed on February 10, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on November 4, 2026. Its latest current report, a Form 8-K, was filed on November 4, 2026 (7.01 Regulation FD Disclosure).

### Key facts

- **Latest annual report:** 10-K, Feb 10, 2026
- **Latest quarterly report:** 10-Q, Nov 4, 2026
- **Latest 8-K:** 8-K, Nov 4, 2026
- **Filings, last 12 months:** 79
- **Insider forms, last 12 months:** 49 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 3
- **SEC central index key:** 0000064803

Filings as listed by SEC EDGAR at Nov 18, 2026, 09:35 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000064803](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

CVS Health: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/cvs-20260930.htm) | Nov 4, 2026 | Sep 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm) | Aug 5, 2026 | Jun 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/cvs-20260331.htm) | May 6, 2026 | Mar 31, 2026 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm) | Feb 10, 2026 | Dec 31, 2025 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/cvs-20250930.htm) | Oct 29, 2025 | Sep 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/cvs-20250630.htm) | Jul 31, 2025 | Jun 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/cvs-20250331.htm) | May 1, 2025 | Mar 31, 2025 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/cvs-20241231.htm) | Feb 12, 2025 | Dec 31, 2024 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/cvs-20240930.htm) | Nov 6, 2024 | Sep 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/cvs-20240630.htm) | Aug 7, 2024 | Jun 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/cvs-20240331.htm) | May 1, 2024 | Mar 31, 2024 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm) | Feb 7, 2024 | Dec 31, 2023 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/cvs-20230930.htm) | Nov 1, 2023 | Sep 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/cvs-20230630.htm) | Aug 2, 2023 | Jun 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/cvs-20230331.htm) | May 3, 2023 | Mar 31, 2023 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/cvs-20221231.htm) | Feb 8, 2023 | Dec 31, 2022 | Annual report |

The latest 16 of 36 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

CVS Health: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312526446150/d148827d8k.htm) | Nov 4, 2026 | Nov 4, 2026 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000107/cvs-20261104.htm) | Nov 4, 2026 | Nov 4, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312526354096/d129035d8k.htm) | Aug 17, 2026 | Aug 13, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000097/cvs-20260805.htm) | Aug 5, 2026 | Aug 5, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000082/cvs-20260514.htm) | May 18, 2026 | May 14, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000051/cvs-20260506.htm) | May 6, 2026 | May 6, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000017/cvs-20260318.htm) | Mar 19, 2026 | Mar 18, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000009/cvs-20260210.htm) | Feb 10, 2026 | Feb 10, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000082/cvs-20251209.htm) | Dec 9, 2025 | Dec 9, 2025 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312525289805/d172430d8k.htm) | Nov 20, 2025 | Nov 20, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000036/cvs-20251029.htm) | Oct 29, 2025 | Oct 29, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312525211349/d57621d8k.htm) | Sep 22, 2025 | Sep 22, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312525181862/d32562d8k.htm) | Aug 15, 2025 | Aug 11, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000023/cvs-20250731.htm) | Jul 31, 2025 | Jul 31, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000015/cvs-20250515.htm) | May 20, 2025 | May 15, 2025 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/cvs-20250501.htm) | May 1, 2025 | May 1, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312525075089/d948665d8k.htm) | Apr 8, 2025 | Apr 7, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000006/cvs-20250212.htm) | Feb 12, 2025 | Feb 12, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312524279907/d882067d8k.htm) | Dec 17, 2024 | Dec 16, 2024 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/64803/000119312524274362/d910925d8k.htm) | Dec 10, 2024 | Dec 10, 2024 | 8.01 Other Events 9.01 Financial Statements and Exhibits |

The latest 20 of 159 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

CVS Health: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 1 |
| Oct 2026 | 0 |
| Sep 2026 | 0 |
| Aug 2026 | 0 |
| Jul 2026 | 0 |
| Jun 2026 | 3 |
| May 2026 | 15 |
| Apr 2026 | 9 |
| Mar 2026 | 4 |
| Feb 2026 | 0 |
| Jan 2026 | 2 |
| Dec 2025 | 4 |

CVS Health: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000112/xslF345X06/form4.xml) | Nov 6, 2026 | Nov 6, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000092/xslF345X06/form4.xml) | Jun 29, 2026 | Jun 26, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000088/xslF345X06/form4.xml) | Jun 1, 2026 | May 31, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000086/xslF345X06/form4.xml) | Jun 1, 2026 | May 31, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000084/xslF345X06/form4.xml) | May 22, 2026 | May 20, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000090514826002617/xslF345X06/form4.xml) | May 21, 2026 | May 19, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000080/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000078/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000076/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000074/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000072/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000070/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000068/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000066/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000064/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000062/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000060/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000058/xslF345X06/form4.xml) | May 15, 2026 | May 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000056/xslF345X06/form4.xml) | May 11, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/64803/000006480326000043/xslF345X06/form4.xml) | Apr 2, 2026 | Mar 31, 2026 |

The latest 20 of 580 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

CVS Health: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000119312526349359/xslSCHEDULE_13G_X02/primary_doc.xml) | Aug 13, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/64803/000210011926000439/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 29, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000010290926001096/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 26, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000205211325002537/xslSCHEDULE_13G_X01/primary_doc.xml) | Jul 16, 2025 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/64803/000142284825000113/xslSCHEDULE_13G_X01/primary_doc.xml) | May 13, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000157641925000710/xslSCHEDULE_13G_X01/primary_doc.xml) | Apr 17, 2025 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/64803/000119312524256941/d793980dsc13g.htm) | Nov 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000201238324002307/us1266501006_102424.txt) | Oct 24, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000110465924020723/tv0723-cvshealthcorp.htm) | Feb 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000108636424004861/us1266501006_012624.txt) | Jan 26, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000110465923015748/tv0700-cvshealthcorp.htm) | Feb 9, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000130655023008221/us1266501006_020723.txt) | Feb 7, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000110465922016939/tv0700-cvshealthcorp.htm) | Feb 9, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000083423722003861/us1266501006_013122.txt) | Feb 1, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000110465921017877/tv0663-cvshealthcorp.htm) | Feb 10, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000083423721003733/us1266501006_012921.txt) | Jan 29, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000110465920018334/tv01629-cvshealthcorp.htm) | Feb 12, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000083423720005407/us1266501006_020420.txt) | Feb 5, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000093247119005064/cvshealthcorp.htm) | Feb 11, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/64803/000021545719007265/us1266501006_020819.txt) | Feb 11, 2019 | — |

The latest 20 of 22 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

CVS Health: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000130817926000202/cvs014969-defa14a.htm) | Apr 3, 2026 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000130817926000201/cvs014969-def14a.htm) | Apr 3, 2026 | May 14, 2026 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000130817925000387/cvs012729_defa14a.htm) | Apr 4, 2025 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000130817925000386/cvs012729_def14a.htm) | Apr 4, 2025 | May 15, 2025 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000130817924000464/lcvs2024_defa14a.htm) | Apr 5, 2024 | — | CVS HEALTH CORPORATION - DEFA14A |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000130817924000463/lcvs2024_def14a.htm) | Apr 5, 2024 | May 16, 2024 | CVS HEALTH CORPORATION - DEF 14A |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000130817923000607/cvs4106991-defa14a.htm) | Apr 7, 2023 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000130817923000606/cvs4106991-def14a.htm) | Apr 7, 2023 | — | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000119312522239219/d741829ddefa14a.htm) | Sep 7, 2022 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000119312522238319/d344935ddefa14a.htm) | Sep 6, 2022 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000120677422000966/cvs3990751-defa14a.htm) | Apr 1, 2022 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000120677422000965/cvs3990751-def14a.htm) | Apr 1, 2022 | May 11, 2022 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000120677421000976/cvs3833491-defa14a.htm) | Apr 2, 2021 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000120677421000974/cvs3833491-def14a.htm) | Apr 2, 2021 | May 13, 2021 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000094787120000444/ss173045_defa14a.htm) | May 6, 2020 | — | DEFINITIVE ADDITIONAL MATERIALS |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000094787120000405/ss172308_defa14a.htm) | Apr 24, 2020 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000094787120000403/ss172217_defa14a.htm) | Apr 24, 2020 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000094787120000318/ss170787_defa14a.htm) | Apr 3, 2020 | — | EXECUTIVE COMPENSATION OVERVIEW |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/64803/000120677420001054/cvs3650331-defa14a.htm) | Apr 3, 2020 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/64803/000120677420001053/cvs3650331-def14a.htm) | Apr 3, 2020 | May 14, 2020 | DEFINITIVE PROXY STATEMENT |

The latest 20 of 26 in EDGAR's recent list.

**Everything else (178 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

CVS Health: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000006480326000110/xslForm13F_X02/primary_doc.xml) | Nov 5, 2026 | Sep 30, 2026 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000006480326000101/xslForm13F_X02/primary_doc.xml) | Aug 6, 2026 | Jun 30, 2026 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/64803/000006480326000090/cvs-20260622.htm) | Jun 23, 2026 | Dec 31, 2025 |  |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000122498326000006/xsl144X01/primary_doc.xml) | May 22, 2026 | — | Notice of proposed sale |
| [S-8](https://www.sec.gov/Archives/edgar/data/64803/000119312526236998/d144664ds8.htm) | May 22, 2026 | — | Registration statement for employee plans |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/64803/000119312526236988/d74214ds3asr.htm) | May 22, 2026 | — | Short-form registration statement |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000194984626000310/xsl144X01/primary_doc.xml) | May 21, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000195004726004274/xsl144X01/primary_doc.xml) | May 8, 2026 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000006480326000054/xslForm13F_X02/primary_doc.xml) | May 7, 2026 | Mar 31, 2026 |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/64803/000130817926000203/cvs014969-ars.pdf) | Apr 3, 2026 | Dec 31, 2025 | ANNUAL REPORT TO SECURITY HOLDERS |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000119312526051367/xslForm13F_X02/primary_doc.xml) | Feb 13, 2026 | Dec 31, 2025 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000119312525260806/xslForm13F_X02/primary_doc.xml) | Oct 31, 2025 | Sep 30, 2025 |  |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000151149125000003/xsl144X01/primary_doc.xml) | Aug 19, 2025 | — | Notice of proposed sale |
| [424B2](https://www.sec.gov/Archives/edgar/data/64803/000119312525179105/d936256d424b2.htm) | Aug 12, 2025 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/64803/000119312525178205/d936256dfwp.htm) | Aug 12, 2025 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/64803/000119312525177483/d936256d424b3.htm) | Aug 11, 2025 | — | Prospectus |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000095012325006907/xslForm13F_X02/primary_doc.xml) | Aug 1, 2025 | Jun 30, 2025 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/64803/000006480325000018/cvshealth11-k2024.htm) | Jun 26, 2025 | Dec 31, 2024 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787125000445/xslForm13F_X02/primary_doc.xml) | May 2, 2025 | Mar 31, 2025 |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/64803/000094787125000358/ss4660537_ars.pdf) | Apr 4, 2025 | Dec 31, 2024 | 2024 ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000197236225000228/xsl144X01/primary_doc.xml) | Mar 5, 2025 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787125000137/xslForm13F_X02/primary_doc.xml) | Feb 13, 2025 | Dec 31, 2024 |  |
| [424B2](https://www.sec.gov/Archives/edgar/data/64803/000119312524271505/d899678d424b2.htm) | Dec 5, 2024 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/64803/000119312524270171/d918708dfwp.htm) | Dec 4, 2024 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/64803/000119312524269437/d899678d424b3.htm) | Dec 3, 2024 | — | Prospectus |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/64803/000000000024012922/filename1.pdf) | Nov 21, 2024 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/64803/000094787124000945/filename1.htm) | Nov 21, 2024 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/64803/000000000024012804/filename1.pdf) | Nov 19, 2024 | — |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787124000867/xslForm13F_X02/primary_doc.xml) | Nov 8, 2024 | Sep 30, 2024 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787124000669/xslForm13F_X02/primary_doc.xml) | Aug 9, 2024 | Jun 30, 2024 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/64803/000006480324000021/cvshealth11-k2023.htm) | Jun 20, 2024 | Dec 31, 2023 |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/64803/000094787124000519/ss3402476_s8.htm) | May 23, 2024 | — | REGISTRATION STATEMENT |
| [424B2](https://www.sec.gov/Archives/edgar/data/64803/000119312524134264/d826150d424b2.htm) | May 8, 2024 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/64803/000119312524133245/d826150dfwp.htm) | May 7, 2024 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/64803/000119312524132634/d826150d424b3.htm) | May 7, 2024 | — | Prospectus |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787124000428/xslForm13F_X02/primary_doc.xml) | May 3, 2024 | Mar 31, 2024 |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/64803/000121465924006914/d416243px14a6g.htm) | Apr 16, 2024 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/64803/000094787124000352/ss3215074_ars.pdf) | Apr 5, 2024 | Dec 31, 2023 | ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000195004724001034/xsl144X01/primary_doc.xml) | Feb 16, 2024 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787124000102/xslForm13F_X02/primary_doc.xml) | Feb 9, 2024 | Dec 31, 2023 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787123001036/xslForm13F_X02/primary_doc.xml) | Nov 3, 2023 | Sep 30, 2023 |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787123000818/xslForm13F_X02/primary_doc.xml) | Aug 4, 2023 | Jun 30, 2023 |  |
| [144](https://www.sec.gov/Archives/edgar/data/64803/000197236223000556/xsl144X01/primary_doc.xml) | Aug 3, 2023 | — | Notice of proposed sale |
| [S-8](https://www.sec.gov/Archives/edgar/data/64803/000094787123000807/ss2300944_s8.htm) | Aug 2, 2023 | — | REGISTRATION STATEMENT |
| [11-K](https://www.sec.gov/Archives/edgar/data/64803/000006480323000026/cvshealth11-k2022.htm) | Jun 27, 2023 | Dec 31, 2022 |  |
| [424B2](https://www.sec.gov/Archives/edgar/data/64803/000119312523158967/d471466d424b2.htm) | Jun 1, 2023 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/64803/000119312523156738/d469716dfwp.htm) | May 30, 2023 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/64803/000119312523156062/d471466d424b3.htm) | May 30, 2023 | — | Prospectus |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/64803/000094787123000633/ss2096393_s3asr.htm) | May 25, 2023 | — | REGISTRATION STATEMENT |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/64803/000000000023005149/filename1.pdf) | May 15, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/64803/000094787123000580/filename1.htm) | May 15, 2023 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/64803/000000000023005019/filename1.pdf) | May 11, 2023 | — |  |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/64803/000094787123000532/xslForm13F_X02/primary_doc.xml) | May 5, 2023 | Mar 31, 2023 |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/64803/000121465923006443/p51231px14a6g.htm) | May 3, 2023 | — |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/64803/000094787123000513/ss2014993_s8.htm) | May 2, 2023 | — | REGISTRATION STATEMENT |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/64803/000121465923005984/b426230px14a6g.htm) | Apr 26, 2023 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/64803/000094787123000435/ss1942074-ars.pdf) | Apr 7, 2023 | Dec 31, 2022 |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/64803/000094787123000391/ss1912944_s8.htm) | Mar 29, 2023 | — | REGISTRATION STATEMENT |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/64803/000094787123000301/ss1843165_dfan14a.htm) | Mar 7, 2023 | — | SOLICITING MATERIAL |
| [424B2](https://www.sec.gov/Archives/edgar/data/64803/000119312523040195/d460539d424b2.htm) | Feb 15, 2023 | — | Prospectus |

The latest 60 of 178 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 5 — Annual statement of beneficial ownership**

An insider's annual statement of holdings in the company's equity securities.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form PRE 14A — Preliminary proxy statement**

A preliminary proxy statement subject to review by the SEC staff.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is CVS Health's latest annual report (10-K)?**

CVS Health filed its latest Form 10-K with the SEC on February 10, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did CVS Health file its latest 10-Q?**

On November 4, 2026 for the period ended September 30, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has CVS Health reported on Form 8-K recently?**

Its latest 8-K was filed on November 4, 2026 (7.01 Regulation FD Disclosure). In the last twelve months the items it reported most often were: 2.02 Results of Operations and Financial Condition (4 reports); 5.02 Departure or Election of Directors or Officers; Officer Compensation (3 reports); 7.01 Regulation FD Disclosure (3 reports). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for CVS in the last year?**

49 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 6, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of CVS Health?**

EDGAR lists 3 Schedule 13D or 13G filings about CVS Health in the last twelve months, the latest on August 13, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “CVS Health (CVS) SEC filings: latest 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/CVS/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
